NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
4.180
+0.190 (4.76%)
At close: Dec 5, 2025, 4:00 PM EST
4.225
+0.045 (1.08%)
After-hours: Dec 5, 2025, 7:59 PM EST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $481.81 million as of December 5, 2025. Its market cap has increased by 485.80% in one year.
Market Cap
481.81M
Enterprise Value
319.68M
1-Year Change
485.80%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $481.81M, an increase of 249.02%. That is a compound annual growth rate of 23.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 459.91M | 564.43% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |